Found: 31
Select item for more details and to access through your institution.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy.
- Published in:
- Proteomics, 2015, v. 15, n. 2/3, p. 365, doi. 10.1002/pmic.201400214
- By:
- Publication type:
- Article
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2084, doi. 10.3390/cancers16112084
- By:
- Publication type:
- Article
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5429, doi. 10.3390/cancers14215429
- By:
- Publication type:
- Article
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5152, doi. 10.3390/cancers13205152
- By:
- Publication type:
- Article
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3358, doi. 10.3390/cancers13133358
- By:
- Publication type:
- Article
Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2527, doi. 10.3390/cancers13112527
- By:
- Publication type:
- Article
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 906, doi. 10.3390/cancers13040906
- By:
- Publication type:
- Article
Identification of stably expressed reference small non-coding RNAs for micro RNA quantification in high-grade serous ovarian carcinoma tissues.
- Published in:
- Journal of Cellular & Molecular Medicine, 2016, v. 20, n. 12, p. 2341, doi. 10.1111/jcmm.12927
- By:
- Publication type:
- Article
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 12, p. 1554, doi. 10.3390/cells8121554
- By:
- Publication type:
- Article
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-162
- By:
- Publication type:
- Article
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The novel serine protease tumor-associated differentially expressed gene15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 9, p. 1898
- By:
- Publication type:
- Article
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.
- Published in:
- BMC Clinical Pathology, 2012, v. 12, n. 1, p. 22, doi. 10.1186/1472-6890-12-22
- By:
- Publication type:
- Article
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.
- Published in:
- Oncology Letters, 2016, v. 12, n. 4, p. 2493, doi. 10.3892/ol.2016.5008
- By:
- Publication type:
- Article
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28901-9
- By:
- Publication type:
- Article
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
- Published in:
- Theranostics, 2021, v. 11, n. 6, p. 2987, doi. 10.7150/thno.45157
- By:
- Publication type:
- Article
Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0113781
- By:
- Publication type:
- Article
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.690201
- By:
- Publication type:
- Article
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02651-y
- By:
- Publication type:
- Article
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.818613
- By:
- Publication type:
- Article
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.584022
- By:
- Publication type:
- Article
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01287
- By:
- Publication type:
- Article
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 1, p. 14, doi. 10.1002/ijc.20408
- By:
- Publication type:
- Article
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer.
- Published in:
- ISRN Obstetrics & Gynecology, 2012, p. 1, doi. 10.5402/2012/245756
- By:
- Publication type:
- Article
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 9, p. 1815, doi. 10.1515/cclm-2013-0151
- By:
- Publication type:
- Article
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 12, p. 2189, doi. 10.1515/cclm-2011-0757
- By:
- Publication type:
- Article
L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 4, p. 637, doi. 10.1002/ijc.34035
- By:
- Publication type:
- Article